Novo's double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer Ingelheim
Novo's double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer Ingelheim
Body unavailable. Use the original source.
Novo's double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer Ingelheim
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.